Poxel SA announced that Richard N. Kender has joined the company's Board of Directors as an independent Board member. Mr. Kender brings POXEL more than 35 years of experience in pharmaceutical licensing and strategic partnerships as well as finance, was most recently the Senior Vice President of Business Development and Corporate Licensing for Merck and Co. Inc. Mr. Kender has spent his entire career at Merck & Co.

Inc. He started in accounting and finance roles of increasing responsibility and moved into Corporate Development in 1994.